Vice President, Global Market Access & Pricing

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers.  The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers.   Our pipeline includes RAS(ON) Inhibitors designed to target diverse oncogenic RAS protein variants. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

As we prepare for the global commercialization of our first product, initially Pancreatic Cancer, we are building the Global Commercial Development organization. We are seeking a visionary, enterprise-minded leader to establish and lead the Global Market Access & Pricing team. This role will be instrumental in shaping global market access and pricing strategies, pricing architecture and value narratives that are resonant across diverse payer landscapes.

The position reports to the SVP, Global Commercial Development, and will serve as a core member of the global commercial development leadership team, and work cross-functionally to influence long-term growth, patient impact, and company valuation.

Responsibilities:

Global Market Access & Pricing Strategy

• Formulate and define pricing and reimbursement strategies to support optimal access and reimbursement outcomes across target markets/regions.

• Develop a global pricing architecture, reference pricing mitigation, net pricing corridors and an optimal launch sequencing strategy.

• Craft a compelling global payer and healthcare system value proposition, oversee the development of the Global Value Dossier (GVD) and payer negotiation materials, and disseminate to target markets/regions.

• Partner with members of the Disease Area Strategy teams, to help shape clinical development priorities - including RevMed medicines and combination regimens.

• Ensure clinical development programs generate the right evidence needed for payer/HTA evaluations (study designs, endpoints, etc)

• Identify global market access risks and opportunities, integrating insights into product strategies and Target Product Profiles (TPPs).

• Partner with clinical development and regulatory affairs to incorporate payer and patient relevant endpoints into clinical development plans.

• Work closely with the HEOR team to ensure 1) alignment between market access needs and health economic research plans for pipeline assets; and 2) full integration of adequate HEOR/evidence deliverables in the global access strategy.

• Engage with Region teams to incorporate payer, policy insights and global trends into access planning.

Launch Readiness & Market Engagement

• Lead global payer research and early engagement with HTA bodies (e.g., G-BA, NICE, HAS, AIFA, Chuikyo).

• Build and maintain strong cross-functional partnerships with Clinical, Commercial Development, Regulatory, Medical Affairs, and HEOR,

• Prepare and submit reimbursement and HTA dossiers in priority markets aligned with the global access and commercialization strategy.

Cross-Functional and Team Leadership

• Partner with Medical Affairs, HEOR, Regulatory, and Clinical to ensure integrated evidence strategies reflect payers’ needs.

• Build and lead a high-performing Global Market Access team and partner closely with regional leads and country affiliates.

• Serve as a key leader within the global launch team, actively contributing to go-to-market planning and strategy, demand forecasting, and gross to net scenario modeling.

Policy, Risk & External Engagement

• Monitor evolving global policies and evaluate their impact on access, portfolio and disease area strategies is (e.g., IRA, international reference pricing, transparency laws, EU HTA/JCA, Medical Research Act, etc.).

• Represent the company externally with payers, HTA bodies, trade associations, and policy groups, helping positively shape access environments.

• Coordinate with the U.S. & other regions to align on policy and legislation risks that could impact life cycle management and pricing corridors.

Required Skills, Experience and Education:

• Bachelor’s degree required; advanced degree in Pharmacy, Health Economics, Public Health, Life Sciences, or Business strongly preferred (e.g., PharmD, PhD, MBA).

• 18+ years of progressive leadership in global market access, pricing, and reimbursement within the biopharma industry.

• Demonstrated success launching a first-in-class or specialty therapy in the U.S. and multiple ex-U.S. markets (especially Germany, France, and Japan).

• Demonstrated ability to build global market access strategy from the ground up.

• Deep understanding of global payer systems and HTA processes, including AMNOG, Chuikyo, NICE, and other EU frameworks.

• Experience designing and implementing global pricing strategy, including value-based pricing, launch sequencing, and reference pricing mitigation.

• Proven ability to work cross-functionally and influence executive leadership in a dynamic, resource-constrained, early-stage company.

Preferred Skills:

• Prior experience with Ex-U.S. and U.S. legislation and public policies that impact Global and regional decisions (U.S. IRA, MFN, EU regulations etc.)

• Oncology or rare disease product launch experience preferred.

• Deep experience working with external vendors, consultants, and access agencies to develop payer research, modeling, and dossier development.

• Strong executive presence, with the ability to clearly articulate complex value stories to both internal and external stakeholders.

• Track record of building or scaling global market access functions in a pre-commercial or newly commercial biotech company.

• Strong solution orientation and enterprise mindset.

The base salary range for this full-time position is $284,000 to $355,000 for candidates working onsite at our headquarters in Redwood City, CA. The range displayed on each job posting is intended to be the salary for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our salary ranges are determined by role, level, and location. Individual pay is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.

Please note that base salary is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.

Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.

#LI-Remote